(1S,3R,5S,6R,8R,11R,12S,13S)-3-(3-Furyl)-5-methyl-2,9,14-trioxapentacyclo[11.2.1.1~8,11~.0~1,5~.0~6,12~]heptadecane-10,15-dione(CAS: 20086-06-0)
![(1S,3R,5S,6R,8R,11R,12S,13S)-3-(3-Furyl)-5-methyl-2,9,14-trioxapentacyclo[11.2.1.1~8,11~.0~1,5~.0~6,12~]heptadecane-10,15-dione (1S,3R,5S,6R,8R,11R,12S,13S)-3-(3-Furyl)-5-methyl-2,9,14-trioxapentacyclo[11.2.1.1~8,11~.0~1,5~.0~6,12~]heptadecane-10,15-dione](https://cnstatic.chemtradehub.com/structs/200/20086-06-0-7cf5.webp)
CAS号
相关产品
2-[6-[6-[6-[6-[4,5-Dihydroxy-2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
CAS号: 34620-78-5
其他供应商提供的 (1S,3R,5S,6R,8R,11R,12S,13S)-3-(3-Furyl)-5-methyl-2,9,14-trioxapentacyclo[11.2.1.1~8,11~.0~1,5~.0~6,12~]heptadecane-10,15-dione
基本信息
分子式
C19H20O6
分子量
344.36 g/mol
物理状态
Powder
Physical Properties
熔点
285°C
沸点
574.8℃/760mmHg
闪点
301.4°C
化学标识符
SMILES
CC12CC(OC13CC(C4C2CC5CC4C(=O)O5)OC3=O)C6=COC=C6
InChIKey
QEANLIISUSNNDX-YHPVUIEZSA-N
数据库引用
MDL号
MFCD16660673
常见问题
黄药子素 B是一种具有复杂环状结构的化合物,其分子量约为414 g/mol。该化合物在水中溶解度较低,在有机溶剂中具有较好的溶解性。其结构中包含多个共轭体系,因此表现出一定的反应活性,特别是在氧化和取代反应中表现出较高的选择性。
黄药子素 B的合成通常通过多步反应实现,包括环化、取代和氧化等步骤。常见的合成方法是利用相应的前体化合物,通过钯催化交叉偶联反应、Suzuki偶联反应等手段逐步构建复杂的分子结构。常用的催化剂包括钯盐和相应的配体,产率一般在80%以上。
黄药子素 B作为一种具有特殊结构的化合物,目前主要应用于医药行业。它具有一定的生物活性,可用于开发治疗某些疾病的新药。此外,该化合物也可能在材料科学领域有一定的应用潜力,例如作为有机半导体材料或在聚合物中作为功能添加剂。
在处理黄药子素 B时,应穿戴适当的个人防护装备(PPE),包括实验室外套、防护眼镜和手套。应在通风橱中操作,以避免吸入挥发性物质。如果发生泄露,应立即停止操作,关闭通风橱,并使用适当的吸附剂进行清理。处理完毕后,应及时查阅安全数据表(SDS),以获取更详细的处理和应急措施信息。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序


![4-{(1R,3aS,4R,6aS)-4-[4-(beta-D-Glucopyranosyloxy)-3,5-dimethoxyphenyl]tetrahydro-1H,3H-furo[3,4-c]furan-1-yl}-2,6-dimethoxyphenyl beta-D-glucopyranoside](https://cnstatic.chemtradehub.com/structs/667/66791-77-3-74b7.webp)


![2-[6-[6-[6-[6-[4,5-Dihydroxy-2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol](https://cnstatic.chemtradehub.com/structs/346/34620-78-5-d616.webp)

![2-(3,4-Dihydroxy-5-methoxyphenyl)-5-(beta-D-glucopyranosyloxy)-7-hydroxy-3-chromeniumyl 6-O-{6-deoxy-4-O-[(2E)-3-(4-hydroxyphenyl)-2-propenoyl]-alpha-L-mannopyranosyl}-beta-D-glucopyranoside chloride](https://cnstatic.chemtradehub.com/structs/699/69915-09-9-afab.webp)


![(1S,3R,5S,6R,8R,11R,12S,13S)-3-(3-Furyl)-5-methyl-2,9,14-trioxapentacyclo[11.2.1.1~8,11~.0~1,5~.0~6,12~]heptadecane-10,15-dione — 上海源叶生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce9f132b2de6e8e95a48fe/67ce9f132b2de6e8e95a48fe-logo.webp)
![(1S,3R,5S,6R,8R,11R,12S,13S)-3-(3-Furyl)-5-methyl-2,9,14-trioxapentacyclo[11.2.1.1~8,11~.0~1,5~.0~6,12~]heptadecane-10,15-dione — 成都麦德生科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce336557537e5c8069b4f1/67ce336557537e5c8069b4f1-logo.webp)
![(1S,3R,5S,6R,8R,11R,12S,13S)-3-(3-Furyl)-5-methyl-2,9,14-trioxapentacyclo[11.2.1.1~8,11~.0~1,5~.0~6,12~]heptadecane-10,15-dione — 云南西力生物技术股份有限公司](https://cnstatic.chemtradehub.com/suppliers/67cecac62b2de6e8e95a5839/67cecac62b2de6e8e95a5839-logo.webp)
![(1S,3R,5S,6R,8R,11R,12S,13S)-3-(3-Furyl)-5-methyl-2,9,14-trioxapentacyclo[11.2.1.1~8,11~.0~1,5~.0~6,12~]heptadecane-10,15-dione — 赫澎(上海)生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ceccf22b2de6e8e95a5e0f/67ceccf22b2de6e8e95a5e0f-logo.webp)
![(1S,3R,5S,6R,8R,11R,12S,13S)-3-(3-Furyl)-5-methyl-2,9,14-trioxapentacyclo[11.2.1.1~8,11~.0~1,5~.0~6,12~]heptadecane-10,15-dione — 成都普睿法药物研发有限公司](https://cnstatic.chemtradehub.com/suppliers/67ced46a2b2de6e8e95a701a/67ced46a2b2de6e8e95a701a-logo.webp)